A ANIVIVE
Live / Registered — Registered (as of 26 Sept 2023)
What this means for you
Registered since 26 Sept 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87891442
- Registration number
- 7176344
- Mark type
- Design + words
- Filed
- 24 Apr 2018
- Published for opposition
- 19 May 2020
- Registered
- 26 Sept 2023
- Attorney of record
- Ian W. Gillies
Goods and services
- Class 005 — Pharmaceuticals: Nutraceuticals for the purpose of treating animal diseases, animal conditions and animal illnesses in the field of veterinary medicine in the nature of autoimmune disorders, oncologic disorders, renal and urinary tract disorders, neurologic disorders, musculoskeletal disorders, infectious disease disorders, dermatologic disorders, ophthalmic disorders, cardiovascular disorders, respiratory disorders, endocrine disorders, metabolic disorders including obesity, gastrointestinal disorders; Pharmaceuticals, namely, pharmaceuticals for the purpose of treating animal diseases, animal conditions and animal illnesses in the field of veterinary medicine in the nature of veterinary pharmaceutical preparations for the treatment of autoimmune disorders, oncologic disorders, renal and urinary tract disorders, neurologic disorders, musculoskeletal disorders, infectious disease disorders, dermatologic disorders, ophthalmic disorders, cardiovascular disorders, respiratory disorders, endocrine disorders, metabolic disorders including obesity, gastrointestinal disorders; Vaccines in the field of veterinary medicine; Therapeutic pharmaceuticals for the purpose of treating animal diseases, animal conditions and animal illnesses in the field of veterinary medicine in the nature of veterinary pharmaceutical preparations for the treatment of autoimmune disorders, oncologic disorders, renal and urinary tract disorders, neurologic disorders, musculoskeletal disorders, infectious disease disorders, dermatologic disorders, ophthalmic disorders, cardiovascular disorders, respiratory disorders, endocrine disorders, metabolic disorders including obesity, gastrointestinal disorders
- Class 042 — Scientific and technological services: Drug discovery services for veterinary medicine; providing pharmaceutical and medical research services and clinical, medical and scientific research information in the field of animal health; analysis services for veterinary medicine, namely, clinical, medical and scientific research; obtaining, recording, analyzing, reporting and modeling data for animal health purposes, namely, electronic monitoring and reporting of clinical information, namely, age, sex, breed, neuter status, body weight, body condition score, blood pressure, heart rate, frequency and character of respiration, appetite, presence or absence of vomiting, activity level, food and water intake, frequency and character of urination and defecation, of animals, using computers or sensors; platform as a service featuring computer software platforms and providing temporary use of non-downloadable computer software for use in database management, for use as a spreadsheet, for word processing, for statistical analysis, data aggregation, data processing, report generation, data sharing, remote data management, remote project management, and data analysis in the field of veterinary medicine for animal health purposes; platform as a service featuring computer software platforms and providing temporary use of non-downloadable computer software for assisting in drug discovery in the nature of managing clinical trials for animal health purposes; platform as a service featuring computer software platforms and providing temporary use of non-downloadable computer software to facilitate ordering and delivery of medications and treatment to animal owners, distributors and veterinary health care providers for animal health purposes
Owner
- Anivive Lifesciences, Inc, Long Beach, CA, US
- Anivive Lifesciences, Inc, Long Beach, CA, US
- Anivive Lifesciences, Inc, Long Beach, CA, US
Prosecution history
- 26 Sept 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 26 Sept 2023 — REGISTERED-PRINCIPAL REGISTER
- 23 Aug 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 22 Aug 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 31 Jul 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Jul 2023 — USE AMENDMENT FILED
- 14 Jul 2023 — TEAS STATEMENT OF USE RECEIVED
- 01 Mar 2023 — ASSIGNED TO EXAMINER
- 08 Feb 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Feb 2023 — SOU EXTENSION 5 GRANTED
- 11 Jan 2023 — SOU EXTENSION 5 FILED
- 26 Jan 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Jan 2023 — SOU TEAS EXTENSION RECEIVED
- 21 Jun 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jun 2022 — SOU EXTENSION 4 GRANTED